Editas Medicine, Inc. (EDIT) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Editas Medicine, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:05.294 Good morning and welcome to the Editas Medicine second quarter 2024 conference 00:00:05.294 -- 00:00:09.417 call. All participants are now in a listen-only mode. 00:00:09.417 -- 00:00:14.181 There will be a question and answer session at the end of this call. 00:00:14.181 -- 00:00:17.564 This call is being recorded at the company's request. 00:00:17.564 -- 00:00:22.028 I would like to turn the call over to Christy Barnett, Corporate Communications and Investor 00:00:22.028 -- 00:00:23.830 Relations at Editas Medicine. 00:00:23.830 -- 00:00:25.830 Thank 00:00:26.192 -- 00:00:31.460 you, Brittany. good morning everyone and welcome to our second quarter 2024 conference 00:00:31.460 -- 00:00:36.725 call earlier this morning we issued a press release providing our financial results 00:00:36.725 -- 00:00:42.091 and recent corporate updates a replay of today's call will be available in the investors 00:00:42.091 -- 00:00:46.895 section of our website approximately two hours after its completion 00:00:46.895 -- 00:00:51.079 after our prepared remarks we will open the call for q a 00:00:51.079 -- 00:00:55.987 as a reminder Various remarks that we make during this call about the company's future 00:00:55.987 -- 00:01:01.210 expectations, plans, and prospects constitute forward-looking statements 00:01:01.210 -- 00:01:05.673 for the purposes of the safe harbor provisions under the Private Securities Litigation 00:01:05.673 -- 00:01:08.464 Reform Act of 1995. 00:01:08.735 -- 00:01:14.479 Actual results may differ materially from those indicated by these forward-looking statements 00:01:14.479 -- 00:01:19.562 as a result of various important factors, including those discussed in the risk 00:01:19.562 -- 00:01:24.751 factors section of our most ...